Twist Bioscience Corporation
TWSTNASDAQHealthcare● Active
$70.04
+$0.82(+1.18%)
Market Cap$4.4B
P/E Ratio—
52W High$72.99
52W Low$23.3
Twist Bioscience Corporation (TWST) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · TWST · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-09 | 2024-09 | 2023-09 | 2022-09 | 2021-09 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.38B | $0.31B | $0.25B | $0.20B | $0.13B |
| Cost of Revenue | $0.19B | $0.18B | $0.16B | $0.12B | $0.08B |
| Gross Profit | $0.19B | $0.13B | $0.09B | $0.08B | $0.05B |
| Gross Margin %(computed) | 50.72% | 42.61% | 36.61% | 41.38% | 39.08% |
| Operating Expenses | |||||
| R&D Expenses | $0.08B | $0.09B | $0.11B | $0.12B | $0.07B |
| G&A Expenses | $0.24B | $0.00B | $0.19B | $0.00B | $0.00B |
| Total Operating Expenses | $0.33B | $0.35B | $0.31B | $0.32B | $0.20B |
| Operating Income | ($0.14B) | ($0.22B) | ($0.22B) | ($0.23B) | ($0.15B) |
| Operating Margin %(computed) | -36.18% | -70.56% | -88.60% | -115.33% | -115.41% |
| Interest Income | $0.01B | $0.02B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.08B) | ($0.21B) | ($0.20B) | ($0.23B) | ($0.15B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | ($0.01B) | ($0.00B) |
| Net Income | ($0.08B) | ($0.21B) | ($0.20B) | ($0.22B) | ($0.15B) |
| Net Margin %(computed) | -20.63% | -66.69% | -83.48% | -107.02% | -114.94% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.30 | $-3.60 | $-3.60 | $-4.04 | $-3.15 |
| Wtd Avg Shares | 0.06B | 0.06B | 0.06B | 0.05B | 0.05B |
| EBITDA | ($0.05B) | ($0.18B) | ($0.17B) | ($0.21B) | ($0.14B) |
| EBITDA Margin %(computed) | -13.83% | -56.46% | -71.05% | -103.99% | -108.75% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Twist Bioscience Corporation data
About Twist Bioscience Corporation (TWST) Income Statement
Twist Bioscience Corporation (TWST) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, TWST reported revenue of $0.38B, gross profit of $0.19B (gross margin 50.72%), and net income of ($0.08B) — a net profit margin of -20.63%.
Frequently asked questions
TWST · 4 questionsTwist Bioscience Corporation (TWST) reported revenue of $0.38B for 2025, up 20.3% year-over-year.
TWST revenueTWST salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08